ALSUntangled No. 27: Precision Stem Cell

References

• http://www.alsuntangled.com/open.php. Accessed 2/5/15.
   Google Scholar
• The ALSUntangled Group. ALSUntangled: Introducing the Table of Evidence. Amyotrophic Lateral Sclerosis2014;Early Online: 1–4.
   Google Scholar
• http://www.precisionstemcell.com/about-Jason-R-Williams-MD.cfm. Accessed 2/5/15.
   Google Scholar
• http://www.precisionstemcell.com/Joint-Pain-Treatments.cfm. Accessed 10/20/14.
   Google Scholar
• http://www.precisionstemcell.com/PDF/Rolando-McClain.pdf. Accessed 2/10/15.
   Google Scholar
• http://www.precisionstemcell.com/ALS-Treatment.cfm. Accessed 2/10/15.
   Google Scholar
• Email communications between Dr. Williams, Eric Valor and Richard Bedlack, 2013–2014.
   Google Scholar
• Abdanipour A, Tiraihi T, Delshad A.Trans-differentiation of the adipose tissue-derived stem cells into neuron-like cells expressing neurotrophins by selegiline. Iranian Biomedical Journal. 2011;15:113–21.
   PubMedGoogle Scholar
• http://www.alsworldwide.net/Precision.html. Accessed 2/14/15.
   Google Scholar
• http://www.healthintheglobalvillage.com/2013/05/06/precision-stemcell-selling-stem-cells-treating-individuals-with-als-as-human-guinea-pigs/. Accessed 2/14/15.
   Google Scholar
• http://www.neuralgene.com/index.cfm. Accessed 2/14/15.
   Google Scholar
• http://www.neuralgene.com/news.cfm. Accessed 2/14/15.
   Google Scholar
• http://www.neuralgene.com/board-of-directors.cfm. Accessed 2/14/15.
   Google Scholar
• Zhao W, Beers DR, Appel SH. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol. 2013;8:888–99.
   PubMed Web of Science ®Google Scholar
• Tovar-y-Romo L, Ramirez-Jarquin U, Lazo-Gomez R, Tapia R. Trophic factors as modulators of motor neuron physiology and survival: implications for ALS therapy. Frent Cell Neurosci. 2014;8:61.
   PubMedGoogle Scholar
• Lewis C, Suzuki M.Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis. Stem Cell Research and Therapy. 2014;5:32.
   PubMedGoogle Scholar
• Madrigal M, Rao K, Riordan N.A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med. 2014;12:260.
   PubMed Web of Science ®Google Scholar
• Marconi S, Bonaconsa M, Scambi I, Squintani G, Rui W, Turano E, et al.Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model. Neuroscience. 2013;248:333–43.
   PubMed Web of Science ®Google Scholar
• Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H.Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med. 2013;2:455–63.
   PubMed Web of Science ®Google Scholar
• Uccelli A, Milanese M, Principato M, Morando S, Bonifacino T, Vergani L, et al.Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis. Mol Med. 2012;18: 794–804.
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhang C, Zhou S, Xie Y, Wang Y, Huang H, et al.Human mesenchymal stromal cells ameliorate the phenptype of SOD1-G93A ALS mice. Cytotherapy. 2007;9:414–26.
   PubMedGoogle Scholar
• Vercelli A, Mereuta O, Garbossa D, Muraca G, Mareschi K, Rustichelli D, et al.Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2008;31:395–405.
   PubMed Web of Science ®Google Scholar
• Kim H, Kim H, Choi M, Hwang S, Nam K, Kim H, et al.Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci Lett. 2010;468:190–4.
   PubMed Web of Science ®Google Scholar
• Corti S, Nuzzardo M, Nardini M, Donadoni C, Salani S, Simone C, et al.Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis. Hum Mol Genet. 2010;19:3782–96.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Rodrigues M, Mirtyl S, Turner S, Mitha S, Sodhi J, et al.Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS. PLoS One 2012;7:e31254.
   PubMed Web of Science ®Google Scholar
• Knippenberg S, Thau N, Dengler R, Brinker T, Petri S.Intracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of ALS. PLoS One 2012;7:e36857.
   PubMed Web of Science ®Google Scholar
• Ludolph A, Bendotti C, Blaugrund E, Chio A, Greensmith L, Loeffler J, et al. Guidelines for pre-clinical animal research in ALS/MND: a consensus meeting. Amyotroph Lateral Scler. 2010;11:38–45.
   PubMed Web of Science ®Google Scholar
• Lunn J, Sakowski S, Feldman E. Concise review of stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future. Stem Cells. 2014; 32:1099–109.
   PubMed Web of Science ®Google Scholar
• http://www.patientslikeme.com/members/124890/treatment_histories/676582. Accessed 2/14/15.
   Google Scholar
• Lyons JL, Elakkat D, Gireesh M, Trivedi J, Bell R, Cettomai D, et al. Fatal exserohilum meningitis and central nervous system vasculitis after cervical epidural methylprednisolone injection. Ann Intern Med. 2012;157:835–6.
   PubMedGoogle Scholar